Astec Lifesciences Ltd
NSE:ASTEC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 5-Year Average (23.1), the stock would be worth ₹-77.45 (110% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -220.4 | ₹740.25 |
0%
|
| 5-Year Average | 23.1 | ₹-77.45 |
-110%
|
| Industry Average | 13.9 | ₹-46.85 |
-106%
|
| Country Average | 17.7 | ₹-59.33 |
-108%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
₹14.9B
|
/ |
Jan 2026
₹-79.8m
|
= |
|
|
₹14.9B
|
/ |
Mar 2026
₹253.4m
|
= |
|
|
₹14.9B
|
/ |
Mar 2027
₹1.1B
|
= |
|
|
₹14.9B
|
/ |
Mar 2028
₹1.6B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
A
|
Astec Lifesciences Ltd
NSE:ASTEC
|
15.6B INR | -220.4 | -18.6 | |
| US |
|
Corteva Inc
NYSE:CTVA
|
53.3B USD | 13 | 48.5 | |
| CA |
|
Nutrien Ltd
TSX:NTR
|
47.9B CAD | 7.4 | 14.9 | |
| CN |
|
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
|
198.4B CNY | 25.1 | 23.4 | |
| CL |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
24.9B USD | 27.1 | 42.3 | |
| CN |
|
Zangge Mining Co Ltd
SZSE:000408
|
135.8B CNY | 80.6 | 29 | |
| US |
|
CF Industries Holdings Inc
NYSE:CF
|
18.8B USD | 6.2 | 12.9 | |
| NO |
|
Yara International ASA
OSE:YAR
|
134.4B NOK | 6.1 | 10.5 | |
| SA |
|
SABIC Agri-Nutrients Company SJSC
SAU:2020
|
53.8B SAR | 8.2 | 12.4 | |
| RU |
|
PhosAgro PAO
MOEX:PHOR
|
923.5B RUB | 4.9 | 8 | |
| CN |
|
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
|
74.9B CNY | 18.2 | 22.6 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 11.9 |
| Median | 17.7 |
| 70th Percentile | 27.8 |
| Max | 47 834.4 |
Other Multiples
Astec Lifesciences Ltd
Glance View
Astec LifeSciences Ltd. engages in the manufacture and sale of agrochemicals and pharmaceutical intermediates. The company is headquartered in Mumbai, Maharashtra and currently employs 506 full-time employees. The company went IPO on 2009-11-25. The firm operates through the Agrochemicals segment. The company manufactures a range of fungicides, insecticides, herbicides and intermediates for its global customers. The Company’s product and intermediates include triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, silane derivatives, fluorinated aromatic, aliphatic and heterocyclic intermediates, fluorinated aromatic amines, fluorinated pyridine derivatives, fluorinated aromatic carboxylic acids, fluorinated benzyl alcohols, fluorinated ketones and benzophenones, fluorinated heterocyclic mercaptans, heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans and heterocyclic sulfonyl chlorides. The company has two multipurpose production sites at Mahad.
